When administered intratumorally in an orthotopic GBM-CD133+ xenograft mouse model, nanoparticle-formulated miR145 significantly reduced tumorigenesis and improved animal survival when combined with radiotherapy and TMZ, compared to that observed in animals treated with PU-PEI per se [149]. The gene discussed is PROM1; the disease is glioblastoma.